Survey Study on Barrett's Esophagus Screening
NCT04408105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 725
Last updated 2025-10-22
Summary
The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal Adenocarcinoma (EAC).
Conditions
- Gastroesophageal Reflux Disease
- Barrett's Esophagus
- Esophagus Adenocarcinoma
Interventions
- BEHAVIORAL
-
Primary Care Provider Survey
To assess PCP demographics, attitudes, and perceived barriers to BE screening, we have developed a PCP survey using a theoretical model of physician behavior based on Social Cognitive Theory and the Theory of Reasoned Action. This approach has proven effective in colorectal cancer and hepatocellular carcinoma screening. This model includes domains of provider background and experience, screening practices, perceptions of screening, physician influences, and practice environment and practice patterns. To assess PCP knowledge of BE screening, we have designed 9 clinical vignettes that will categorize provider responses into under-, appropriate, and over-use of BE screening. Survey questions and vignettes have been adapted from earlier validated surveys. Prior to distribution, the survey and vignettes will be pretested and refined based on a cognitive interview about the survey among a convenience sample of 10 PCPs.
- BEHAVIORAL
-
Gastroenterologist Survey
To assess GI demographics, attitudes, and perceived barriers to BE screening, we have developed a GI survey using a theoretical model of physician behavior based on Social Cognitive Theory and the Theory of Reasoned Action. This approach has proven effective in colorectal cancer and hepatocellular carcinoma screening. This model includes domains of provider background and experience, screening practices, perceptions of screening, physician influences, and practice environment and practice patterns. To assess GI knowledge of BE screening, we have designed 9 clinical vignettes that will categorize provider responses into under-, appropriate, and over-use of BE screening. Survey questions and vignettes have been adapted from earlier validated surveys. Prior to distribution, the survey and vignettes will be pretested and refined based on a cognitive interview about the survey among a convenience sample of 10 GIs.
- BEHAVIORAL
-
Patient Survey
To assess patient knowledge, attitudes, and barriers to completion of BE screening, we will use a theoretical model of patient behavior on the Health Behavior Framework to guide selection of relevant variables for survey development including 4 domains: knowledge about BE and EAC, potential barriers to BE screening completion, patient attitudes and demographic information. Prior to distribution, the survey will be refined and pretested among a sample of 10 patients with each participant completing a cognitive interview prior to distribution.
Sponsors & Collaborators
-
American College of Gastroenterology
collaborator OTHER -
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Sachin Wani, MD · University of Colorado, Denver
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-19
- Primary Completion
- 2021-09-23
- Completion
- 2025-10-01
Countries
- United States
Study Locations
More Related Trials
-
Detection of Barrett s Esophagus in Patients Without GERD Symptoms
NCT04880044 ·Status: COMPLETED ·Phase: NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
NCT05530343 ·Status: RECRUITING ·Phase: NA
-
Novel Method of Surveillance in Barrett's Esophagus
NCT00955019 ·Status: COMPLETED
-
Study of Endoscopic Barrett's Esophagus Diagnosis
NCT00591461 ·Status: TERMINATED
-
Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
NCT03459339 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
NCT06746623 ·Status: RECRUITING ·Phase: NA
-
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
NCT00903136 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
NCT00445653 ·Status: COMPLETED
-
Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus
NCT05846971 ·Status: UNKNOWN ·Phase: NA
-
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
NCT02514525 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium
NCT02249975 ·Status: COMPLETED ·Phase: NA
-
Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy
NCT03191604 ·Status: COMPLETED
-
Early Increase in Blood Supply in Patients With Barrett's Esophagus
NCT01188980 ·Status: COMPLETED
-
Confocal Laser Probe to Treat Barrett's Esophagus
NCT02852525 ·Status: COMPLETED ·Phase: NA
-
Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?
NCT01373125 ·Status: COMPLETED
-
Novel Imaging Techniques in Barrett's Esophagus
NCT00576498 ·Status: COMPLETED ·Phase: NA
-
A Trial Comparing Yield of Confocal Endomicroscopy Guided Biopsies
NCT01030263 ·Status: TERMINATED ·Phase: PHASE4
-
The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE
NCT05818072 ·Status: RECRUITING ·Phase: NA
-
High Definition White Light Endoscopy and Narrow Band Imaging for the Assessment of Barrett's Disease After Endoscopic Therapy
NCT01360801 ·Status: TERMINATED
-
Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus
NCT00987857 ·Status: UNKNOWN ·Phase: NA
-
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
NCT02066701 ·Status: COMPLETED
-
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
NCT02106910 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Biopsy Techniques in Barrett's Esophagus Patients
NCT05578677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Imaging Enhanced Endoscopy for the Screening of Barrett's Esophagus
NCT01976351 ·Status: TERMINATED
-
Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue
NCT00909350 ·Status: COMPLETED